Derek Archila's
Stock Forecasts
26.92%
7/26 win trades
Price targets by Derek Archila
Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
---|---|---|---|---|---|
![]() Kezar Life Sciences, Inc. KZR | 9 months ago | $9 132.52% upside | $6.26 | TheFly | Previous targets (0) |
![]() C4 Therapeutics, Inc. CCCC | 9 months ago | $12 337.95% upside | $4.31 | TheFly | Previous targets (0) |
![]() Kymera Therapeutics, Inc. KYMR | 9 months ago | $57 33.89% upside | $48.54 | StreetInsider | Previous targets (0) |
![]() Zymeworks Inc. ZYME | 10 months ago | $12 -14.89% downside | $13.28 | StreetInsider | Previous targets (0) |
![]() Acelyrin, Inc. SLRN | 11 months ago | $15 560.79% upside | $5.72 | TheFly | |
![]() Nurix Therapeutics, Inc. NRIX | 11 months ago | $32 223.55% upside | $25.16 | StreetInsider | Previous targets (0) |
![]() Celldex Therapeutics, Inc. CLDX | 12 months ago | $44 113.79% upside | $36.02 | TheFly | |
![]() Q32 Bio Inc. QTTB | 12 months ago | $95 5119.78% upside | $50.61 | StreetInsider | Previous targets (0) |
![]() argenx SE ARGX | about 1 year ago | $542 -17.48% downside | $394.47 | TheFly | Previous targets (0) |
![]() Annexon, Inc. ANNX | over 1 year ago | $14 539.26% upside | $5.99 | StreetInsider | |
![]() Apellis Pharmaceuticals, Inc. APLS | over 1 year ago | $48 80.31% upside | $43.6 | TheFly | Previous targets (0) |
![]() Ventyx Biosciences, Inc. VTYX | over 1 year ago | $16 520.15% upside | $8.42 | StreetInsider | Previous targets (0) |
![]() Arvinas, Inc. ARVN | over 1 year ago | $63 782.35% upside | $37.87 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Daan Vandenberk
Kepler Capital
100%
win rate
Covering:
Laura Sutcliffe
UBS
50%
win rate
Christopher Liu
Leerink Partners
25%
win rate
Allison Bratzel
Piper Sandler
20%
win rate